Page Stephen J, Levine Peter, Leonard Anthony, Szaflarski Jerzy P, Kissela Brett M
Department of Rehabilitation Sciences,University of Cincinnati Academic Medical Center, Cincinnati, Ohio, USA.
Phys Ther. 2008 Mar;88(3):333-40. doi: 10.2522/ptj.20060029. Epub 2008 Jan 3.
This single-blinded randomized controlled trial compared the efficacy of a reimbursable, outpatient, modified constraint-induced therapy (mCIT) protocol (half-hour therapy sessions occurring 3 days per week in which subjects used the more affected arm combined with less affected arm restriction 5 days per week for 5 hours; both of these regimens were administered during a 10-week period) with that of a time-matched exercise program for the more affected arm or a no-treatment control regimen.
Thirty-five subjects with chronic stroke participated in the study.
The Action Research Arm Test (ARAT), Fugl-Meyer Assessment of Motor Recovery After Stroke (FM), and Motor Activity Log (MAL) were administered to the subjects.
After intervention, significant differences were observed on the ARAT and MAL Amount of Use and Quality of Movement scales, all in favor of the mCIT group.
The data affirm previous findings suggesting that this reimbursable, outpatient protocol increases more affected arm use and function. Magnitude of changes was consistent with those reported in more intense protocols, such as constraint-induced therapy.
本单盲随机对照试验比较了一种可报销的门诊改良强制性使用疗法（mCIT）方案（每周3天进行半小时治疗，受试者每周5天使用患侧上肢并限制健侧上肢使用5小时，两种方案均在10周内实施）与针对患侧上肢的时间匹配运动计划或无治疗对照方案的疗效。
35名慢性中风患者参与了本研究。
对受试者进行了行动研究臂测试（ARAT）、中风后运动恢复的Fugl-Meyer评估（FM）和运动活动日志（MAL）。
干预后，在ARAT以及MAL的使用量和运动质量量表上观察到显著差异，均有利于mCIT组。
数据证实了先前的研究结果，表明这种可报销的门诊方案可增加患侧上肢的使用和功能。变化幅度与更强化的方案（如强制性使用疗法）所报告的一致。
